ETF Holdings Breakdown of AUTL

AUTL institutional holdings

The adjusted close for AUTL on 2025-11-11 was 1.50

The following institutional investment holdings of AUTL have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	139,691	USD 209,537 12.0%	1.50
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	139,691	USD 209,537 12.0%	1.50
Total =		279,382	USD 419,074

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with AUTL

Analysts Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) PT at $9.12

Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) have received an average rating of “Buy” from the five analysts that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have updated their coverage […] - 2025-09-15 05:04:54

Brokerages Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Price Target at $9.12

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) has been given an average recommendation of “Buy” by the five brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock […] - 2025-08-19 02:16:53

Autolus Therapeutics (NASDAQ:AUTL) Trading Down 3.5% Following Analyst Downgrade

Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) fell 3.5% during trading on Wednesday after Wells Fargo & Company lowered their price target on the stock from $6.00 to $5.00. Wells Fargo & Company currently has an overweight rating on the stock. Autolus Therapeutics traded as low as $2.02 and last […] - 2025-08-15 02:52:49

Alps Advisors Inc. Sells 15,481 Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)

Alps Advisors Inc. reduced its stake in shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 7.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 199,709 shares of the company’s stock after selling 15,481 shares during the quarter. Alps Advisors […] - 2025-07-18 04:50:54

Vontobel Holding Ltd. Trims Stock Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)

Vontobel Holding Ltd. decreased its position in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 5.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 138,783 shares of the company’s stock after selling 8,636 shares during the period. Vontobel Holding Ltd.’s […] - 2025-07-09 05:04:55

Exchange Traded Concepts LLC Has $108,000 Stake in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)

Exchange Traded Concepts LLC grew its holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 67.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 69,993 shares of the company’s stock after acquiring an additional 28,127 shares during the period. Exchange Traded Concepts LLC’s holdings in Autolus Therapeutics were worth $108,000 […] - 2025-06-25 04:57:00

Two Sigma Advisers LP Acquires 15,400 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)

Two Sigma Advisers LP grew its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 4.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 333,400 shares of the company’s stock after acquiring an additional 15,400 shares during the period. Two Sigma […] - 2025-06-03 05:00:53

OMERS ADMINISTRATION Corp Invests $85,000 in Autolus Therapeutics plc (NASDAQ:AUTL)

OMERS ADMINISTRATION Corp bought a new position in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,300 shares of the company’s stock, valued at approximately $85,000. A number of other […] - 2025-05-21 05:26:48

Brokerages Set Autolus Therapeutics plc (NASDAQ:AUTL) Price Target at $9.32

Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […] - 2025-05-13 02:14:55

Renaissance Technologies LLC Purchases 368,071 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)

Renaissance Technologies LLC lifted its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 146.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 618,942 shares of the company’s stock after purchasing an additional 368,071 shares during the period. Renaissance Technologies LLC’s holdings in Autolus Therapeutics were worth $1,455,000 as of its most recent […] - 2025-04-29 04:44:58

Autolus Therapeutics (NASDAQ:AUTL) Given New $10.00 Price Target at Truist Financial

Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective trimmed by Truist Financial from $11.00 to $10.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts have also recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and […] - 2025-04-02 04:14:47

Autolus Therapeutics plc (NASDAQ:AUTL) Receives Average Rating of “Buy” from Analysts

Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the […] - 2025-03-26 03:53:00

Daiwa Securities Group Inc. Has $56,000 Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL)

Daiwa Securities Group Inc. grew its stake in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 55.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,743 shares of the company’s stock after purchasing an additional 8,479 shares during the quarter. Daiwa […] - 2025-03-18 05:42:52

Autolus Therapeutics plc (NASDAQ:AUTL) Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB boosted its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 30.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,300 shares of the company’s stock after buying an additional 17,300 shares during […] - 2025-03-04 06:46:54

Back to Listing

Disclaimer